| Daniel B Bolton, | |
|
24 Doctors Ln Ste 202, Clarion, PA 16214-8574 | |
| (814) 226-2500 | |
| (814) 226-2501 |
| Full Name | Daniel B Bolton |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 24 Doctors Ln Ste 202, Clarion, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164915807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OT018231 (Pennsylvania) | Primary |
| Entity Name | Ahn Emergency Group Of Clarion County Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194262980 PECOS PAC ID: 4183900624 Enrollment ID: O20170417001081 |
News Archive
Zebrafish exposed to the leading cannabinoids found in cannabis in the earliest stages of development suffer a significant drop in neural activity later in life, according to a University of Alberta study that has implications for prenatal development in humans.
Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.
UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus - which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 - that allow it to take over host cells in order to replicate.
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel B Bolton, 121 Doctors Ln, Clarion, PA 16214-8515 Ph: (814) 226-3494 | Daniel B Bolton, 24 Doctors Ln Ste 202, Clarion, PA 16214-8574 Ph: (814) 226-2500 |
News Archive
Zebrafish exposed to the leading cannabinoids found in cannabis in the earliest stages of development suffer a significant drop in neural activity later in life, according to a University of Alberta study that has implications for prenatal development in humans.
Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.
UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus - which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 - that allow it to take over host cells in order to replicate.
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
› Verified 1 days ago
Mahreen Nizarali Gilani, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Clarion, PA 16214 Phone: 814-226-9500 | |
Dr. Erin Minich Bowser, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18 Sportsman Dr, Clarion, PA 16214 Phone: 814-226-6062 | |
Saad Shaukat, Family Medicine Medicare: Medicare Enrolled Practice Location: 24 Doctors Ln Ste 202, Clarion, PA 16214 Phone: 814-226-2500 Fax: 814-226-2501 | |
Omais Ahmed, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Clarion, PA 16214 Phone: 814-226-9500 | |
Panayiota Voutsinas, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Doctors Ln, Suite 202, Clarion, PA 16214 Phone: 814-226-2500 | |
Jeffrey P Karls, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 30 Pinnacle Dr Ste 101a, Clarion, PA 16214 Phone: 814-297-7070 Fax: 814-297-7072 |